Robin Chan

Robin Chan is a seasoned biotechnology professional with extensive experience in leadership roles, currently serving as Chief Scientist and Vice President of Strategic Partnerships at AliveX Biotech since September 2021. Previously, Robin held the position of Director of Business Development at My-BioMed Biotechnology Co., focusing on commercializing precision medicine innovations in China. Robin also contributed as a Partner at Berkeley Skydeck Biochina, facilitating the support of early-stage biomedicine firms transitioning to the Chinese market. Earlier entrepreneurial efforts included ownership of Danyi Company, a food trading entity. Academic experience at Columbia University Medical Center as Director of the Lipidomics Research Facility involved pioneering lipidomics technology and mentoring emerging scientists. Robin's educational background includes an MBA from Columbia Business School and a PhD in Biochemistry from the National University of Singapore.